Tuesday - March 03, 2026

Category Archives: Business

Hanley Investment Group Arranges Pre-Sale of New Construction 7-Eleven Commercial Fueling Lanes (CFL) Prototype in San Bernardino, Calif., for $3.03 Million

First Offering of Its Kind to Sell as a Stand-Alone Investment in California; CFL Expands Adjacent Existing High Performing C-Store and Traditional Fuel Station SAN BERNARDINO, Calif. – Hanley Investment Group Real Estate Advisors, a nationally recognized real estate brokerage … Continue reading →

Cough in Idiopathic Pulmonary Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Algernon Pharma, Seyltx, Melius Pharma, NeRRe Therapeutics, Trevi

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Cough in Idiopathic Pulmonary Fibrosis pipeline constitutes 5+ key companies continuously working towards developing 5+ Cough in Idiopathic Pulmonary Fibrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, … Continue reading →

Diabetic Kidney Disease Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Orbsen Therapeutics, Dimerix Bioscience, Inversago Pharma, CSL

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Diabetic Kidney Disease pipeline constitutes key companies continuously working towards developing Diabetic Kidney Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Ecominsights Expands Amazon Intelligence Platform With Keyword Intelligence, Product Analytics, AI-Powered Tools, and Verified Data Infrastructure

Ecominsights Ecominsights launched four core features on its Amazon intelligence platform: Keyword Intelligence (search volume, trends, keyword insights), Product Analytics (sales tracking, pricing, market share), AI-Powered Tools (natural language queries, automated insights, content generation), and Trusted Data (verified, daily-updated, secure … Continue reading →

Non Alcoholic Fatty Liver Disease Clinical Trial Pipeline Shows Potential with Active Contributions from 90+ Key Companies | DelveInsight

DelveInsight’s, “Non-Alcoholic Fatty Liver Disease Pipeline Insight 2026” report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in Non-Alcoholic Fatty Liver Disease pipeline landscape. It covers the Non Alcoholic Fatty Liver Disease pipeline drug profiles, including clinical and … Continue reading →

Neuroendocrine Tumors Clinical Trial Pipeline Accelerates as 70+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Neuroendocrine tumors Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Neuroendocrine tumors pipeline landscape. It covers the Neuroendocrine Tumors pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

NK Cell Lymphoma Clinical Trial Pipeline Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Natural Killer Cell Therapies Pipeline Insight 2026” report provides comprehensive insights about 100+ companies and 140+ pipeline drugs in Natural Killer Cell Therapies pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also … Continue reading →

Multiple Sclerosis Treatment Pipeline Shows Strong Momentum as 75+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Multiple Sclerosis Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Multiple Sclerosis pipeline landscape. It covers the Multiple Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →